Table 3 Association of LHR-P with demographics and disease characteristics
From: Expression of the luteinizing hormone receptor (LHR) in ovarian cancer
Factors | Na | LHR Expression Observed in Tumor Cells | p-value* | |
|---|---|---|---|---|
≤ 50% | > 50% | |||
Age at Diagnosis | ||||
< 60 | 130 | 24 (18%) | 106 (82%) | 0.09 |
≥ 60 | 101 | 10 (10%) | 91 (90%) | |
Histology | ||||
Serous | 159 | 19 (12%) | 140 (68%) | 0.11 |
Other | 72 | 15 (21%) | 57 (79%) | |
Pathologic Stage | ||||
I/II | 68 | 15 (22%) | 53 (78%) | 0.065 |
III/IV | 163 | 19 (12%) | 144 (88%) | |
Silberberg’s Grade | ||||
1 | 27 | 8 (30%) | 19 (70%) | 0.037 |
2 or 3 | 204 | 26 (13%) | 178 (87%) | |
Persistent Disease | ||||
No | 143 | 25 (17%) | 118 (83%) | 0.18 |
Yes | 88 | 9 (10%) | 79 (90%) | |